Pharmaceutical Gelatin

Pharmaceutical Gelatin Market Outlook

The global pharmaceutical gelatin market is projected to reach USD 3.2 billion by 2035, growing at a compound annual growth rate (CAGR) of approximately 6.5% during the forecast period from 2025 to 2035. The growth of this market can be attributed to the increasing demand for pharmaceutical capsules, rising prevalence of chronic diseases, and the growing nutraceuticals sector. Additionally, advancements in technology and production processes are expected to enhance the quality and application range of gelatin, further driving market growth. The burgeoning interest in personalized medicine and dietary supplements is also anticipated to fuel demand for gelatin-based products. Furthermore, the rise in research and development activities in the pharmaceutical industry is set to provide a significant boost to the pharmaceutical gelatin market.

Growth Factor of the Market

The pharmaceutical gelatin market is experiencing significant growth primarily due to the increasing utilization of gelatin in various pharmaceutical applications. As a versatile ingredient, gelatin is widely used in the formulation of capsules and drug delivery systems, which are essential in ensuring effective medication administration. The rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular conditions necessitates innovative pharmaceutical formulations, which often include gelatin. Moreover, the nutraceutical sector is thriving, with consumers increasingly seeking health supplements, functional foods, and dietary products that utilize gelatin as a key ingredient. This trend is further supported by the growing awareness around preventative healthcare and the importance of dietary choices, leading to increased investment in gelatin-based nutraceuticals. The expansion of online distribution channels is another factor contributing to market growth, as it provides consumers with easy access to a variety of gelatin products.

Key Highlights of the Market

• The pharmaceutical gelatin market is projected to reach USD 3.2 billion by 2035.
• It is expected to grow at a CAGR of 6.5% during the forecast period from 2025 to 2035.
• Increasing demand for hard and soft gelatin capsules is a major growth driver.
• Rising consumer interest in nutraceuticals and dietary supplements boosts market demand.
• Advancements in production technologies enhance the application range of pharmaceutical gelatin.

By Product Type

Hard Gelatin Capsules:

Hard gelatin capsules are one of the most popular forms of drug delivery due to their ease of swallowing and ability to mask unpleasant tastes and odors. They are generally composed of gelatin derived from bovine or porcine sources, offering significant benefits in terms of stability and bioavailability of the encapsulated drug. The rising demand for solid dosage forms, particularly in the pharmaceutical industry, is expected to drive the growth of hard gelatin capsules. Furthermore, the increasing trend toward personalized medicine and customized formulations is leading to innovations in capsule design and production methods, increasing the overall appeal of hard gelatin capsules in the market.

Soft Gelatin Capsules:

Soft gelatin capsules are increasingly favored in the pharmaceutical segment because of their ability to encapsulate liquid formulations, providing an alternative to traditional tablets and hard capsules. They offer improved absorption rates and bioavailability for various types of drugs, making them particularly suitable for oil-based formulations and active ingredients that may be poorly soluble in water. The growing demand for liquid-filled capsules in the nutraceutical sector is anticipated to further enhance the market for soft gelatin capsules. Additionally, advancements in encapsulation technologies are enabling the launch of new products, thereby reinforcing the growth of this segment.

Microencapsulation:

Microencapsulation is a technique used to encapsulate substances to achieve desired release properties, improve stability, and mask taste. In the pharmaceutical gelatin market, microencapsulation is gaining traction for its ability to enhance the performance of active ingredients by protecting them from degradation and controlling their release profiles. This technology is particularly valuable in the formulation of dietary supplements and pharmaceuticals, where the controlled release of active compounds can significantly improve efficacy. As the demand for advanced drug delivery systems grows, so does the potential for microencapsulation to play a crucial role in the future of pharmaceutical formulations.

Coating Materials:

Coating materials are vital in the pharmaceutical industry for protecting capsules and tablets from environmental factors, enhancing appearance, and improving patient compliance. Gelatin-based coatings are favored for their biocompatibility and performance. The increasing demand for coated tablets and capsules, which provide modified release properties and improved taste masking, is expected to drive growth in this segment. Moreover, with a growing focus on patient-centric formulations, the demand for effective coating materials is likely to rise, particularly in the nutraceutical and pharmaceutical sectors, as manufacturers seek to enhance product performance and consumer acceptance.

Others:

This segment encompasses various forms of gelatin products that do not fall into the primary categories of hard and soft capsules, microencapsulation, or coating materials. Innovations in gelatin applications continue to emerge, including the development of gelatin-based films and gels used in pharmaceutical applications and drug delivery systems. As the industry seeks alternatives and enhancements in drug formulation, this 'Others' category is expected to see growth driven by unique applications across a range of health and wellness products, alongside traditional uses in pharmaceutical production.

By Application

Nutraceuticals:

The nutraceuticals sector is one of the most significant applications of pharmaceutical gelatin, driven by the growing consumer awareness around health and wellness. Gelatin is widely used in dietary supplements, functional foods, and beverages, providing important health benefits such as joint support, digestive health, and skin elasticity. The burgeoning trend of preventative healthcare, combined with a shift towards self-medication, has led to an increase in the consumption of nutraceutical products, thereby propelling the demand for gelatin. Furthermore, innovations in gelatin formulations are enabling manufacturers to create more effective nutraceutical solutions, which are likely to enhance their popularity and drive market growth.

Pharmaceuticals:

Within the pharmaceutical industry, gelatin is primarily utilized for the formulation of hard and soft capsules, which are crucial for the delivery of medications. Its applications extend to various drug delivery systems, which require encapsulation to enhance stability and bioavailability. The rising prevalence of chronic diseases and the aging population are key factors influencing the growth of this application segment, as they necessitate innovative pharmaceuticals that often incorporate gelatin. The focus on personalized medicine and tailored therapeutic solutions is also leading to advancements in pharmaceutical formulations, further propelling the demand for gelatin in this sector.

Cosmetics:

In the cosmetics sector, gelatin is increasingly used in various formulations for its binding, thickening, and film-forming properties. It plays a critical role in the production of creams, lotions, and serums, contributing to the texture, stability, and effectiveness of cosmetic products. The growing demand for natural and bio-based ingredients in beauty products is driving the exploration of gelatin as a sustainable option. As consumers continue to prioritize quality and efficacy in their skincare and cosmetic routines, the demand for gelatin-based products in this application is expected to rise significantly, showcasing the versatility of gelatin beyond its pharmaceutical uses.

Research:

Research institutions and laboratories utilize gelatin for various applications, including the development of drug delivery systems, biomaterials, and tissue engineering. Its biocompatibility and biodegradability make it an ideal candidate for scientific exploration in pharmaceutical research and development. The growing emphasis on innovative drug formulations, especially in the field of biotechnology, is projected to fuel demand for gelatin in research applications. Furthermore, as research expands in regenerative medicine and bioengineering, the need for gelatin as a foundational material will continue to enhance its significance in the market.

Others:

This category includes various other applications where gelatin is utilized outside the primary sectors of nutraceuticals, pharmaceuticals, cosmetics, and research. These applications may involve the use of gelatin in food products, industrial uses, and more. Innovations and emerging trends in different industries are likely to contribute to the growth of gelatin in these applications. As manufacturers seek to leverage the unique properties of gelatin, including its gelling, binding, and thickening capabilities, the demand for its use in diverse applications is set to increase.

By Distribution Channel

Online Stores:

The rise of e-commerce has dramatically transformed the way consumers access pharmaceutical gelatin products. Online stores provide convenience, wider product selection, and often competitive pricing, making them increasingly popular among consumers. The pandemic has accelerated the shift towards online shopping, and this trend is expected to continue as consumers become accustomed to the ease of purchasing health and wellness products online. The availability of detailed product information and customer reviews on e-commerce platforms further enhances consumer confidence, promoting greater adoption of gelatin-based products through online channels.

Drug Stores:

Drug stores remain a traditional and reliable distribution channel for pharmaceutical gelatin products, particularly hard and soft capsules. These retail outlets provide consumers with immediate access to a variety of medications, supplements, and health-related products, including those containing gelatin. The strategic positioning of drug stores in local communities enhances their accessibility, making them an integral part of the distribution network. As consumers increasingly seek out health solutions in their neighborhoods, drug stores are likely to continue playing a vital role in the growth of the pharmaceutical gelatin market.

Hospitals & Clinics:

Hospitals and clinics serve as critical distribution channels for pharmaceutical gelatin products, particularly in the context of patient care and treatment. Gelatin is often used in the formulation of medications administered within these healthcare settings, such as injectable drugs, dietary supplements, and other therapeutic solutions. The increasing focus on patient-centric care and tailored treatment plans is expected to drive demand for gelatin products in hospitals and clinics. Additionally, as healthcare providers emphasize the use of high-quality ingredients in their formulations, the role of gelatin as a trusted excipient will likely grow in importance.

Specialty Stores:

Specialty stores, which focus on health and wellness products, are becoming key players in the distribution of pharmaceutical gelatin products, particularly within the nutraceutical sector. These stores cater to health-conscious consumers who seek specific dietary supplements, functional foods, and health products that often contain gelatin. The knowledgeable staff and curated product selections in specialty stores provide customers with personalized advice, enhancing the shopping experience. As consumers become more discerning about their health choices, the demand for specialty stores offering high-quality gelatin products is expected to increase.

Others:

This category includes various alternative distribution channels that facilitate the sale of pharmaceutical gelatin products, such as health food stores, supermarkets, and wholesalers. These channels allow for greater accessibility and convenience for consumers seeking health-related products. The growth of various retail formats catering to health and wellness is likely to expand the reach of gelatin products, allowing manufacturers to tap into new customer segments. As the overall demand for health products continues to rise, the 'Others' segment is expected to witness growth as distribution options diversify.

By Ingredient Type

Bovine Gelatin:

Bovine gelatin is derived from cowhide and is widely used in pharmaceutical applications due to its excellent gelling properties and versatility. It is commonly utilized in the production of hard and soft gelatin capsules, as well as in various dietary supplements and functional foods. The increasing demand for bovine gelatin is attributed to its favorable characteristics, including its high quality and ability to serve as an effective excipient for drug delivery systems. Furthermore, as consumers seek out reliable and trusted ingredients in their health products, the popularity of bovine gelatin is anticipated to remain strong in the market.

Porcine Gelatin:

Porcine gelatin, sourced from pigs, is another widely used ingredient in the pharmaceutical gelatin market. It is known for its excellent gelling ability and is often employed in the manufacturing of capsules, jellies, and desserts. The growing acceptance of porcine-derived products in various regions, particularly in the food and pharmaceutical industries, is driving its demand. However, the use of porcine gelatin is subject to cultural and dietary restrictions in certain markets, which may influence its growth. Despite this, the flexibility and unique properties offered by porcine gelatin continue to make it a valuable ingredient in various applications.

Fish Gelatin:

Fish gelatin is becoming increasingly popular as an alternative to bovine and porcine gelatin, particularly for consumers seeking halal or pescatarian options. Derived from fish skin and bones, fish gelatin offers similar gelling properties while meeting dietary restrictions for certain populations. Its growing acceptance in the nutraceutical and pharmaceutical markets is driven by the increasing demand for marine-derived ingredients, which are perceived as healthier alternatives. The rise in consumer demand for sustainable and eco-friendly products is also expected to enhance the appeal of fish gelatin as a viable ingredient in various formulations.

Halal Gelatin:

Halal gelatin is produced in compliance with Islamic dietary laws and has seen a surge in demand due to the growing Muslim population and their preferences for halal-certified products. This type of gelatin can be sourced from bovine or fish and is used in various applications within the pharmaceutical and nutraceutical sectors. The increasing awareness of dietary restrictions and the importance of maintaining halal standards among consumers is driving the growth of this segment. Manufacturers are increasingly focusing on producing halal-certified gelatin to cater to this specific consumer base, thus expanding market opportunities.

Others:

The 'Others' segment encompasses various alternative sources of gelatin that do not fall within the primary categories mentioned above. This may include gelatin derived from alternative animal sources or plant-based gelling agents that mimic gelatin's properties. The exploration of these alternatives is driven by the growing consumer interest in vegan and vegetarian products, leading to innovations in gelatin substitutes. As the market evolves and consumers seek diverse options in their formulations, this segment is expected to see growth and diversification to meet varied dietary preferences.

By Region

North America is one of the leading regions in the pharmaceutical gelatin market, accounting for a substantial share of the global industry. The region's dominance can be attributed to the presence of established pharmaceutical and nutraceutical manufacturers, coupled with a robust healthcare system that emphasizes innovative drug delivery solutions. The increasing prevalence of chronic diseases and the rising demand for dietary supplements further reinforce the growth of the market in North America. Additionally, the focus on research and development activities in the pharmaceutical sector is expected to enhance the region's market growth, with a projected CAGR of 5.8% from 2025 to 2035.

Europe also represents a significant market for pharmaceutical gelatin, driven by the growing demand for gelatin in the nutraceutical and pharmaceutical sectors. Countries such as Germany, France, and the UK are at the forefront of this growth, characterized by a strong emphasis on health and wellness products. The rising awareness around preventative healthcare and innovative drug formulations is expected to propel the demand for gelatin-based products across Europe. As manufacturers increasingly focus on quality and compliance with regulatory standards, the European market is poised for steady growth, contributing significantly to the global pharmaceutical gelatin landscape.

Opportunities

The pharmaceutical gelatin market presents numerous opportunities for growth, particularly in the expanding nutraceutical sector. As consumers become more health-conscious and actively seek dietary supplements that promote overall well-being, manufacturers are presented with the chance to innovate and develop new gelatin-based products. This includes formulating unique blends that enhance nutritional value or targeting specific health concerns, such as joint health or digestive wellness. Furthermore, the trend toward personalized nutrition offers a promising avenue for companies to tailor their gelatin formulations to meet individual consumer needs, thereby increasing market penetration and customer loyalty.

Additionally, the ongoing advancements in technology and manufacturing processes are poised to open new doors for the pharmaceutical gelatin market. Innovations in encapsulation methods, such as microencapsulation and nanoencapsulation, enable the development of more effective drug delivery systems with improved bioavailability. As pharmaceutical companies prioritize research and development to create novel formulations, the demand for high-quality gelatin products is expected to rise. The increasing focus on sustainable and ethical sourcing of raw materials also presents opportunities for manufacturers to differentiate their products in a competitive market, appealing to a growing base of environmentally conscious consumers.

Threats

While the pharmaceutical gelatin market is poised for growth, it is not without its challenges. One of the primary threats is the rising popularity of vegetarian and vegan diets, which discourage the use of animal-derived products such as gelatin. This shift in consumer preferences has led to an increasing demand for plant-based alternatives, posing a significant challenge to traditional gelatin manufacturers. Companies must adapt to these changing market dynamics by exploring innovative plant-based substitutes or modifying their product offerings to cater to a broader audience. Failure to diversify and meet consumer demands could result in lost market share and decreased profitability.

Furthermore, regulatory challenges surrounding the use of animal-derived ingredients may also impact the pharmaceutical gelatin market. Strict regulations regarding sourcing, production, and labeling requirements can create barriers for manufacturers, particularly those operating in regions with stringent food safety laws. Compliance with these regulations not only adds to operational costs but can also lead to delays in bringing new products to market. As the industry continues to evolve, companies must remain vigilant in navigating these challenges to maintain competitiveness and ensure compliance with ever-changing regulations.

Competitor Outlook

• Gelita AG
• PB Gelatins
• Rousselot
• Nitta Gelatin Inc.
• GELITA AG
• Capsugel
• FMC Corporation
• Bhagat Group
• Collagen Solutions Plc
• Haribo GmbH & Co. KG
• Weishardt
• Vegan Gelatin Co.
• GELITA Asia Pacific
• Sonneborn LLC
• Norland Products

The competitive landscape of the pharmaceutical gelatin market is characterized by a mix of established players and emerging companies vying for market share. Key players such as Gelita AG, Rousselot, and PB Gelatins dominate the market due to their extensive product portfolios and strong distribution networks. These companies have invested heavily in research and development to innovate and expand their offerings, enabling them to maintain a competitive edge. Additionally, strategic partnerships and acquisitions have become common strategies among leading companies to enhance their market presence and capabilities, further intensifying competition in the sector.

Emerging companies are capitalizing on the growing trend toward plant-based ingredients and sustainable practices in the pharmaceutical gelatin market. Companies such as Vegan Gelatin Co. are gaining traction by offering alternatives to traditional animal-derived gelatin products, appealing to the growing base of health-conscious and environmentally aware consumers. As competition increases, manufacturers are focusing on differentiation, quality assurance, and compliance with regulatory standards to enhance their market positioning. The emphasis on product innovation and customization is also becoming a crucial factor that companies must address to meet the evolving needs of their customers.

Among the notable players in the pharmaceutical gelatin market, Gelita AG stands out for its commitment to quality and sustainability. With a comprehensive range of gelatin products tailored for various applications, Gelita has positioned itself as a leader in both the pharmaceutical and food sectors. The company has also made significant investments in research and development to enhance product formulations and expand its global reach. Similarly, Rousselot is recognized for its innovative approach to gelatin production, focusing on enhancing product performance and developing customized solutions for its clients. Their dedication to quality and sustainability has solidified their reputation within the industry.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Capsugel
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 GELITA AG
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Gelita AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Rousselot
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Weishardt
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 PB Gelatins
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Bhagat Group
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Sonneborn LLC
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 FMC Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Norland Products
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Vegan Gelatin Co.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Nitta Gelatin Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 GELITA Asia Pacific
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Haribo GmbH & Co. KG
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Collagen Solutions Plc
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Pharmaceutical Gelatin Market, By Application
    • 6.1.1 Nutraceuticals
    • 6.1.2 Pharmaceuticals
    • 6.1.3 Cosmetics
    • 6.1.4 Research
    • 6.1.5 Others
  • 6.2 Pharmaceutical Gelatin Market, By Product Type
    • 6.2.1 Hard Gelatin Capsules
    • 6.2.2 Soft Gelatin Capsules
    • 6.2.3 Microencapsulation
    • 6.2.4 Coating Materials
    • 6.2.5 Others
  • 6.3 Pharmaceutical Gelatin Market, By Ingredient Type
    • 6.3.1 Bovine Gelatin
    • 6.3.2 Porcine Gelatin
    • 6.3.3 Fish Gelatin
    • 6.3.4 Halal Gelatin
    • 6.3.5 Others
  • 6.4 Pharmaceutical Gelatin Market, By Distribution Channel
    • 6.4.1 Online Stores
    • 6.4.2 Drug Stores
    • 6.4.3 Hospitals & Clinics
    • 6.4.4 Specialty Stores
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Pharmaceutical Gelatin Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Pharmaceutical Gelatin market is categorized based on

By Product Type

• Hard Gelatin Capsules
• Soft Gelatin Capsules
• Microencapsulation
• Coating Materials
• Others

By Application

• Nutraceuticals
• Pharmaceuticals
• Cosmetics
• Research
• Others

By Distribution Channel

• Online Stores
• Drug Stores
• Hospitals & Clinics
• Specialty Stores
• Others

By Ingredient Type

• Bovine Gelatin
• Porcine Gelatin
• Fish Gelatin
• Halal Gelatin
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Gelita AG
• PB Gelatins
• Rousselot
• Nitta Gelatin Inc.
• GELITA AG
• Capsugel
• FMC Corporation
• Bhagat Group
• Collagen Solutions Plc
• Haribo GmbH & Co. KG
• Weishardt
• Vegan Gelatin Co.
• GELITA Asia Pacific
• Sonneborn LLC
• Norland Products